TELMIVIB MCT 50 METOPROLOL TARTRATE 50mg. IP + TELMISARTAN 40mg. IP + CHLORTHALIDONE 12.5mg. IP

Telmivib MCT 50 tablets combine metoprolol, telmisartan and chlorthalidone to help control high blood pressure. Main uses: treatment of high blood pressure (hypertension), to lower blood pressure; lowers blood pressure to reduce the risk of fatal and non-fatal cardiovascular events, mainly strokes and heart attacks; for patients who need more than one medicine to reach their blood pressure goals.

Common side effects of Telmivib MCT 50 Tablet include tiredness; dizziness; depression; shortness of breath; slow heart rate (bradycardia); low blood pressure (hypotension). Get medical help at once if you notice worsening heart failure or worsening heart block; bronchospasm (breathing difficulty) in people with asthma or other bronchospastic disease; severe electrolyte imbalance or very low blood pressure.

Each Telmivib MCT 50 tablet contains Metoprolol Tartrate 50 mg + Telmisartan 40 mg + Chlorthalidone 12.5 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Telmivib MCT 50 Tablet only as your doctor advises.

The MRP of Telmivib MCT 50 Tablet is ₹165 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹125.71 and the PTS is ₹113.14.

Each Telmivib MCT 50 tablet contains Metoprolol Tartrate 50 mg + Telmisartan 40 mg + Chlorthalidone 12.5 mg. It comes in a pack of 10x10 (Alu Alu).

Metoprolol Tartrate works as a beta-blocker, slowing the heart rate and easing the heart's workload. Telmisartan blocks the action of angiotensin II, a substance that tightens blood vessels, so the vessels relax. Chlorthalidone is a diuretic that helps the kidneys remove extra salt and water from the body. Working together, the three ingredients lower blood pressure.

Must not be used during pregnancy; if pregnancy is detected, the medicine must be stopped as soon as possible because it can injure the developing baby. Must not be used by patients allergic to any of the three ingredients, including patients allergic to sulfonamide-derived drugs, and must not be used when there is anuria (no urine output). Must not be used in severe bradycardia, greater than first-degree heart block, sick sinus syndrome without a pacemaker, cardiogenic shock, decompensated heart failure, or systolic blood pressure below 100 mm Hg. Must not be taken together with aliskiren by patients with diabetes, and beta-blockers must be avoided in bronchospastic disease such as asthma. Check with a doctor first if you have diabetes, liver disease, kidney disease, thyrotoxicosis or peripheral vascular disease; in pheochromocytoma an alpha-blocker must be started before metoprolol; the medicine must not be stopped abruptly.

Telmivib MCT 50 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.